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INTRODUCTION
In his Origin, Charles Darwin led the foundations to debunk the long-held belief that man and
animals derive from separate lineages, landing the final blow in The Descent of Man. The discovery
in the mid-1980’s that fertilized mammal eggs must have male components to generate healthy
offspring had similarly dramatic consequences on other religious beliefs, as discussed in “Genetics:
immaculate misconception” (1). In the Catholic calendar, the 8th of December is dedicated to the
Virgin Mary. The occasion was celebrated with loud fireworks cracking during the second night
of the 25th course of the EFIS-EJI Ruggero Ceppellini Advanced School of Immunology, held at
Castellammare di Stabia, near Naples, 7th−9th December 2014. A faculty of 13 gathered together
with 60 attendants from 19 countries to discuss the themeMaternal Immune System in Pregnancy.
While the conclusions of the course were not quite as dramatic as Darwin’s and Surani’s, new
exciting concepts were discussed that had already emerged at a previousmeeting held in Cambridge
in 2013 to celebrate the 60th anniversary of Peter Medawar’s famous article on the “immunological
paradox” of pregnancy (2). I had the honor of directing both events, together with Ashley Moffett,
and learned a great deal.
This brief article is a report on the activities during that 25th course, as well as an opportunity
to celebrate the importance of the Ceppellini School to connect young immunologists with leader
scientists in their fields, as well as to spur new collaborations. With the generous support of the
EFIS-EJI, the Bill and Melinda Gates Foundation, and the International Union of Immunological
Societies, a record number of travel fellowships was offered to 13 participants from African
countries, including South Africa, Kenya, Nigeria, Gabon, and Cameroon. This was appropriate
because it is in Sub-Saharan Africa (SSA) that maternal morbidity and mortality is highest due to
pregnancy complications, such as the hypertensive disorder of pregnancy pre-eclampsia, still birth
or intrauterine growth restriction (3).
ACTIVITIES DURING THE 2014 COURSE
On the first day of the course, Silvia Fontana Zappacosta talked about the ethos and history of
the School founded by her late husband Serafino Zappacosta. One of the remits of the School
is to “foster wider interest for immunology and to attract to the discipline young scientists,
also from disadvantaged countries” (4). I introduced the course with a brief synopsis of each
lecturer’s topic and told the story of my own connection to the Ceppellini School. My late maternal
uncle Tommaso (Tommi) Meo trained with Ceppellini himself in the 60’s and 70’s in Turin
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and Basel. Ceppellini made seminal contributions for the
advancement of our understanding of immunogenetics (5).
Among the factors determining pregnancy outcome are immune
system genes—that is combinations of certain variants of genes
coding for Human Leukocyte Antigens (HLA) and Killer-cell
Immunoglobulin-like Receptors (KIR) (6). How odd that part
of my research today was the subject of my uncle’s science
with Ceppellini and that he so excitedly narrated to us on his
summer visits back in our native Southern Italy. John Trowsdale
(University of Cambridge) reviewed the “ABC” of KIR and
HLA, explaining how the system may have evolved to deploy
the two A and B haplotypes that code for KIR receptors on
Natural Killer (NK) cells to bindHLA-C on fetal trophoblast cells.
AshleyMoffett (University of Cambridge) discussed how the KIR
and HLA systems may have evolved and can be used to study
population history (7). Annettee Nakimuli (Makerere University
and Mulago Hospital, Kampala, Uganda) discussed the diverse
KIR and HLA genes that cause susceptibility to or protection
from pregnancy disorders in Europeans and Africans (8). Allison
Elliott (London School of Hygiene and tropical Medicine and
Uganda Virus Research Institute, Entebbe, Uganda) presented
fascinating data on the impact of helminth infection during
pregnancy and the outcomes in the offspring. Angela Santoni
(University of Rome La Sapienza) reviewed leukocyte trafficking
and the changes occurring during pregnancy. On the second
day, Elizabeth Simpson (Imperial College, London, UK) gave
a historical background on multiple histocompatibility antigens
and how the maternal immune system is aware of fetal
antigens yet does not mount an immune response against the
fetus. Tamara Tilburgs (Harvard University, Cambridge, US
and now at the Cincinnati Children’s Hospital, US) discussed
the delicate balance that the maternal immune system must
strike between fetal tolerance and antiviral immunity. Jakob
Michaelsson (Karolinksa Institut, Stockholm, Sweden) reminded
the audience that the fetus also has its immune system that
may engage with maternal antigens, with consequences on
micro-chimerism. Marise Alegre (University of Chicago, US)
revised the evidence that tolerance can be induced experimentally
to transplants. Anthony De Tomaso (University of California
Santa Barbara, US) talked about the strange and fascinating
life of a basal chordate that uses allorecognition to regulate
stem cell parasitism. In the third and last day, Ennio Carbone
(Karolinksa Institute, Stockholm, Sweden and University of
Catanzaro, Italy) opened the lectures with an overview on
tumor immunology. Tom Gajewski (University of Chicago, US)
followed up highlighting the immune pathways in the tumor
microenvironment that may be operating also at the maternal-
fetal interface, with the engagement of several inhibitory
checkpoints. The course ended with my closing lecture on mouse
models of immunogenetics of pregnancy.
In the typical spirit of the Ceppellini School, the presentations
were enriched by ample discussions and debates in which both
faculty and students participated actively. The search for elusive
pathogenic T cells in pregnancy complications was discussed as
it was the antigen specificity of these effector T cells, which most
likely are HLA-C-restricted. Another theme was the importance
of studying human populations in which the prevalence of
pregnancy complications is highest. New technology that can
help visualize lymphocytes at the maternal-fetal interface were
discussed, including imaging approaches. Finally, various routes
of vertical transmission were considered, including through




There were plenty of opportunities for the participants to interact
among each other and with the faculty members over lunches,
coffee breaks, and the poster session. Several collaborations
stemmed from this course and continue till today. Both Anthony
De Tomaso and Allison Elliott, two of the members of the faculty
at this course came to spend a year as visiting Fellows of King’s
College, Cambridge, where myself and Ashley Moffett are also
Fellows. Annette Nakimuli and AshleyMoffett have strengthened
their collaboration and have since initiated a series of initiatives
within the Cambridge-Africa partnership to improve patients
care in the Department of Obstetrics and Gynecology at the
Makerere University, including several trips from Cambridge
obstetricians to visit Uganda. For example, Catherine Aiken,
also at our Department, now mentors Imelda Namagembe’s PhD
thesis in Uganda, that focuses on improving maternal health.
Despite not present at the course, Stephen Tukwasibwe, then
a research assistant in the same hospital of faculty member
Annettee Nakimuli, became interested in the immunogenetics
of pregnancy. Having worked successfully on the genetics of
resistance to malaria and secured a Wellcome Trust PhD grant,
Stephen started his thesis at Makerere University under the
supervision of Annettee Nakimuli and my co-mentorship, to
test the hypothesis that Plasmodium may have selected for those
genetic variants that may protect frommalaria but expose women
to pregnancy complications in SSA. Stephen has since visited
Cambridge several times working at the Pathology Department
as part of his thesis. One of the participants, Iva Filipovic from
Serbia, was completing her MSc degree at Imperial College,
London, during the course and was very keen to learn more on
immunology of pregnancy. She secured a PhD Studentship from
the University of Cambridge Center for Trophoblast Research
and came to work on her PhD as a graduate student of King’s
College and in my laboratory to study the gene expression profile
of innate lymphoid cells in the uterus of mice (9). She is currently
working as a post-doc at the Karolinska Institute and I look
forward to seeing her future successes.
NEW CONCEPTS AND RECENT
PROGRESS IN THE FIELD
Peter Medawar in 1953 famously proposed three mechanisms
underlying placental tolerance: (i) anatomical separation of
mother and fetus; (ii) antigenic immaturity of the fetus; (iii)
immunological unresponsiveness of the mother. Bearing in mind
these proposals were formulated in light of the progress made
during those days in transplantation immunology, and with
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unimaginable less knowledge of the details of the human immune
system then we have today, it is perhaps not surprising that
none of these three mechanisms have been fully substantiated—
although they have influenced generations of immunologists of
reproduction. On the contrary, we know that the placenta is not
such a tight barrier and cells can mix in both directions. We also
know that the fetus is not antigenically immature and the mother
is not unresponsive. Indeed, pregnant women can make both
T cells and antibodies that recognize fetal antigens (e.g., anti-D
antibodies in Rhesus incompatibility).
One major conceptual shift in the immunology of
pregnancy is the understanding that pregnant women are
not immunosuppressed. Changes in the immune system during
pregnancy may however be responsible for the greater morbidity
and mortality of mothers and infants infected with certain
pathogens (10). The emergence of new epidemics has attracted
the attention of investigators who are now addressing the
mechanisms of vertical transmission of certain pathogens,
e.g., Zika virus (11, 12). That microbes are integral part of
human health and disease has become established in the
recent past, perhaps best illustrated by the influence of the
gut microbiota on the immunotherapy of cancer (13)—one of
themes of the 2019 course (Microbes, Immunity and Cancer) of
the Ceppellini School (14). Transplantation immunology also
may be influenced by microbes (15, 16), however the search
for a placental microbiome has so far been elusive (17). Yet,
maternal infections may have repercussions on neuropsychiatric
disorders (18) and the development of the immune system
in the offspring. Clinical trials are ongoing to evaluate the
effectiveness of vaccinating mothers to prevent children’s
allergies (19, 20).
There are obvious selective disadvantages in a strategy
that would suppress the immune system of pregnant women
to allow the implantation and growth of the placenta. The
placenta evolved much later than the immune system and it
is reasonable to think that placentation and immunity have
co-evolved agreeably, rather than embarking in a deleterious
conflict. One illustrative example may be the interactions of
maternal KIR on uterine NK cells with fetal HLA-C molecules
on the placental cells, which may engage in a molecular
conversation that, rather than leading to allorecognition-driven
rejection, may in fact contribute to uterine vascular remodeling
and placental growth (6). Adding to the complexity of the
maternal-fetal interactions is the heterogeneity of immune cells,
revealed recently by singe-cell RNA-sequencing (21) and mass
cytometry (22). Mass cytometry has been applied to study also
the fluctuations in blood immune cells throughout pregnancy
(23, 24). Multiple populations of innate lymphoid cells (9, 21,
25), regulatory T cells (26), and macrophages (27) compose
the diverse immune cell landscape operating at the maternal-
fetal interface, which varies during the stages of pregnancy and
it is therefore difficult to decipher precisely. New technology
such as three-dimensional organoid cell cultures (28) may help
to determine some of the mechanisms underlying placentation
(29). Advances in typing polymorphic KIR and HLA genes
(30, 31) may also help to shed light on the immunogenetics
of pregnancy. Although the interactions of maternal KIR with
fetal HLA-C may be a pivotal one to activate uterine NK cells
and determine the outcome of pregnancy (6), the importance
of the interaction of NK cell receptors with self HLA class
I molecules is emerging, in a process known as NK-cell
education. We have shown recently that NK-cell education
in the uterus may follow different rules than in the blood
(32) and that NK-cell education reduces the risk of pregnancy
complications in women genetically programmed to engage the
inhibitory NKG2A receptor on NK cells (33). The next grand
challenge is to precisely decipher the multiple and changing
interactions between mother and fetus in the decidua, to
eventually manipulate them in order to improve the outcome of
pregnancy (29).
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